Abstract The Native American Pima population has the highest incidence of insulin resistance (IR) and type 2 diabetes mellitus (
Introduction
In the last half of the twentieth century, the incidence of type 2 diabetes (T2DM), previously unrecognized in the Native American Pima population, began to rise. Multiple factors were postulated to be responsible, including environmental and genetic factors Prochazka et al. 1993; Pratley 1998; Bennett 1999; Valencia et al. 1999; Baier and Hanson 2004) . Acyl-CoA dehydrogenase 10 (ACAD10) was one of 30 genes further examined after it demonstrated a significant signal for diabetes in a genome-wide association study (GWAS) . In these studies, a single
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Electronic supplementary material The online version of this article (doi:10.1007/s10545-017-0013-y) contains supplementary material, which is available to authorized users. nucleotide polymorphism (SNP), rs632650, was found to map within intron 2 of ACAD10 (Bian et al. 2010) . The ACAD10 protein C-terminus region, ∼400 amino acid, is homologous to the acyl-CoA dehydrogenase (ACAD) family of mitochondrial flavoproteins that catalyze the α,β-dehydrogenation of various acyl-CoA substrates (Swigoňová et al. 2009 ). At least five ACADs catalyze the α,β-dehydrogenation of fatty acid acyl-CoA esters, the first step in mitochondrial FAO (FAO) . Four other ACADs are involved amino acid catabolism and use various branched-chain acyl-CoA substrates. While ACAD10 has weak activity toward branched-chain substrates R and S, 2-methyl-C15-CoA and is highly expressed in fetal but not adult brain (He et al. 2011) , its physiological role remains unknown.
Skeletal muscle patterns of fatty acid utilization during fasting are associated with obesity-related insulin resistance and altered mitochondrial energy metabolism. These abnormalities are also present in the context of T2DM (Kelley et al. 1999; Adams et al. 2009; Goodpaster 2013; Aguer et al. 2015) . Acylcarnitines (ACNs), key alternate metabolic intermediates of FAO, in the blood of obese and T2DM participants fall into two distinct patterns (Mihalik et al. 2010) . First, both T2DM and obese study participants had similar accumulation of long-chain ACNs that arise from activity in the initial rounds of β-oxidation, consistent with reduced capacity to handle an increased flux at entry into mitochondrial β-oxidation. Individuals with diabetes also displayed an accumulation of various shorter chain ACNs, suggestive of inefficient FAO or interactions between β-oxidation and electron transport chain (ETC). These individuals also showed an inability to efficiently switch from fat metabolism during insulin clamp, as reflected in their inability to lower their ACNs as effectively as either lean or obese individuals (Mihalik et al. 2010) .
Pima have higher rates of T2DM than their counterparts in Mexico and the general US population, and genetic studies have identified a noncoding polymorphism in the ACAD10 gene (Bian et al. 2010) as possibly being causative. In the study we report here, an Acad10-deficient mouse model was characterized to elucidate the physiologic role of ACAD10 gene product in intermediary metabolism and its potential link to T2DM.
Materials and methods

Generation of mutant mice
A heterozygote Acad10 gene-trap knockout mouse model in a SvEv129/BL6 mixed background generated in a total genome knockout mouse project was purchased from Taconic Biosciences (Hudson, NY, USA). Homozygous mice were viable and fertile. Genotyping was done by tail tipping, followed by polymerase chain reaction (PCR) with primers designed to specifically amplify an Acad10-containing DNA fragment. Tissue expression was examined with primers across the predicted coding region of the gene and ACAD10 antigen presence (Fig. 1) . Wild-type and homozygous mouse lines were maintained by breeding to the same SvEv129/BL6 mixed-background strain.
Characterization of mutant mice
Visual observations and weight measurements were performed to monitor the health of wild-type and Acad10-deficient mice over time. Food consumption was determined by weighing the consumed food ad libitum weekly over 5 weeks. Diet was a standard mouse chow [LabDiet (St. Louis, MO, USA) Isopro RMH 3000 with 6.8% long-chain fat]. Male mice were used for most experiments, since they typically exhibit a more severe phenotype when FAO deficient. Females were used, as indicated in the text, to show that the phenotype was not specifically sex limited.
Abdominal micro-magnetic resonance imaging (MRI) was performed with a horizontal-bore, 7-T MRI system from Bruker Biospin, (Billerica, MA, USA), 70/30 with full vital monitoring system to assess accumulation of adipose tissue content in wild-type and Acad10-deficient mice. Blood was collected for analysis in serum separator tubes using a cheek stick. Following standard lung perfusion techniques, Acad10-deficient mouse tissues from young male (∼10-12 weeks) and older male (∼25-26 weeks) mice were isolated following cervical dislocation and then flash frozen in liquid nitrogen for metabolic analysis or preserved in 2.5% glutaraldehyde or 4% paraformaldehyde for histopathology (Pociask et al. 2013) . After fixation, organs were embedded in paraffin and 10-μm sections collected and stained with hematoxylin and eosin (H&E) according to standard protocols. Gomori trichrome staining was performed on muscle tissue samples using standard techniques. Serum isolated from whole blood was used immediately or flash frozen for analysis. Light microscopy was performed in the Mouse Histology Core Laboratory at the Rangos Research Center, the Children's Hospital of Pittsburgh of UPMC. Transmission electron microscopy was performed at the Center for Biologic Imaging at the University of Pittsburgh.
For immunohistochemical and immunofluorescent staining, tissues were harvested and immersed in fixative overnight, as above. Immunohistochemical staining was performed by incubation overnight with primary antibodies, followed by incubation for 1 h with fluorescently labeled secondary antibodies, as described previously (He et al. 2011) . Primary antibodies included an ACAD10 polyclonal antibody generated at Cocalico Biologicals, Inc. (Reamstown, PA< USA) against a recombinant human His-tagged ACAD10 Q635-I1059 expressed and purified from Escherichia coli, anti-MTCO1 antibody as a mitochondrial marker from Abcam (Cambridge, MA, USA), and catalase (N-17) from Santa Cruz Biotechnology, Inc., (Dallas, TX, USA) as a marker for peroxisomes. Primary antibodies were used at dilutions of 1:500. Slides were analyzed using standard confocal microscopy technique.
For biochemical analysis, mouse tissues of heart, liver, lung, muscle, kidney, spleen, and pancreas were flash frozen in liquid nitrogen and extracted and derivatized with pentafluorophenacyl trifluoromethanesulfonate. ACN profiling using ultra-high-performance liquid chromatography tandem mass spectroscopy (UHPLC MS/MS) was performed, as previously described (Houten and Wanders 2010) . Values were quantified using 13-point calibration curves. Creatine kinase and glucose levels were determined using a standard clinical laboratory MS/MS technique at the Division of Pediatric Pathology, Children's Hospital of Pittsburgh. AcylCoA profiling on tissue samples was performed and analyzed for acyl-CoA species, as previously described (Palladino et al. 2012 ). C-reactive protein (CRP) and insulin enzyme-linked immunosorbent assay (ELISA) were performed in triplicate using mouse insulin ELISA and mouse CRP ELISA kits from ALPCO Diagnostics, (Salem, NH, USA). A panel of 23 cytokines was analyzed using a Luminex immunoassay kit from Thermo Fisher Scientific (Grand Island, NY, USA). Blue native PAGE (BN-PAGE) was performed, as previously described (Graves et al. 2012) . Catalytic activity of complexes I and V was visualized on BN-PAGE, as previously described (Van Coster et al. 2001) . Subcellular fractionation of wild-type liver. Liver tissue was freshly harvested and a peroxisomal fraction (P) and a mixed peroxisomal/ mitochondrial fraction (M/P) were prepared, separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), transferred to a membrane, and visualized with ACAD10 antiserum. c Western blot survey of ACAD10 in mouse brain, pancreas, and kidney of a 4-15% SDS-PAGE gel, with 100 μg of tissue extract applied per lane. d Acad10-deficient and wild-type mice average body weight (g). Difference between male wild-type and mutant was statistically significant (two-tailed p value = 0.0006), as was the difference between female genotypes (twotailed p value = 0.0007). e Intra-abdominal fat accumulating in mutant mice. f Micro-magnetic resonance imaging (MRI) of ACAD10 mouse abdominal cavity. Acad10-deficient mice show a significant increase in adipose accumulation over time compared with wild-type control mice of the same background. Top and bottom panels represent different coronal cross sections
Intraperitoneal glucose tolerance test (IPGTT) was performed, as previously described (Rehman et al. 2005) . Briefly, animals were fasted for 5.5 h, and basal glucose levels were measured. Sterile filtered D-glucose was then injected IP at 2 g/kg body weight, and blood samples for glucose measurement were taken at times points 15, 30, 60, 90, and 120 min postinjection. Glucose was analyzed using a handheld Precision Xtra glucometer from Abbott Diabetes Care, (Alameda, CA, USA). For immunoblotting, white adipose and muscle tissues were homogenized in 50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS containing protease inhibitors from Roche (Branchburg, NJ, USA). Thirty micrograms of protein were resolved on precast gradient 4-12% SDS-PAGE and transferred to polyvinylidene fluoride membranes blocked with 5% nonfat dry milk in Trisbuffered saline with Tween 20 for 1 h. Proteins were visualized with primary antibodies (Akt, pAkt, ser473 and GAPDH from Cell Signaling Technologies, Cambridge, MA, USA) diluted in Tris-buffered saline with tween (TBS-T) containing 5% of bovine serum albumin (BSA) incubated overnight at 4°C, and secondary horseradish-peroxidase-conjugated secondary antibodies for 1 h. Signals were detected using the SuperSignal West Dura extended duration substrate from Thermo Fisher Scientific.
RNA extraction for real-time quantitative PRC (RT-qPCR) was performed on tissue samples using RNeasy Fibrous Tissue Mini Kit for muscle, and RNeasy Lipid Tissue Mini Kit for liver and fat from Qiagen (Valencia, CA, USA). For complementary DNA (cDNA) synthesis for use with the RT2 Profiler™ PCR Array Mouse Insulin Signaling Pathway from Qiagen gene panel, RT2 First Strand Kit from Qiagen was used. For detecting phosphoenolpyruvate carboxykinase (PEPCK), liver RNA was extracted using RNeasy purification kit from Qiagen. First-strand cDNA was synthesized from 500 ng RNA using AMV First Strand cDNA Synthesis Kit from New England Biolabs Inc. (Ipswich, MA, USA). RT-PCR was carried out in 10-μl reaction using SYBR green fast master mix from Applied Biosystems, Thermo Fisher Scientific, containing 1 μl of the diluted (1:10) first-strand cDNA. PEPCK was amplified using the following primers: forward 5′-CTTCTCTGCCAAGGTCATCC-3′ and reverse 5′-TTTTGGGGATGGGCAC-3′; results were normalized to 36B4 (forward: 5′-AACTTTGGCATTGTGGAAGG-3′ and reverse: 5′-ACACATTGGGGGTAGGAACA-3′) using 'delta delta Ct' (ΔΔCt).
Mouse open-field testing
To examine locomotor function and behaviors of mutant mice in a new environment, animals were placed for 30 min in an open-field testing chamber (28 x 28 x 40 cm) with a floor divided into equal-sized square fields, and the frequency of a variety of behaviors was determined, as described in the Supplemental Figure legends .
Statistics
Data are presented as mean ± standard deviation (SD) for replicates and analyzed using unpaired Student's t test (VassarStats software; www.vassarstats.net). Statistical significance is indicated in figure legends by the following annotation: *p < 0.05.
Results
Generation of mutant mice
Mutant mice incorporating a gene-trap vector in the Acad10 gene bred well and had normal survival. Genotypes of Acad10-deficient and strain-matched wild-type animals were confirmed by PCR. Subcellular fractionation and Western blotting of wild-type mouse liver extracts were performed. The ACAD10 antigen-purified antibody identified the predicted 119-kDa ACAD10 protein in a combined mitochondrial/peroxisomal (M/P) fraction plus a smaller protein in a more purified peroxisomal fraction (P). However, various protein sizes were seen in different tissues from mutant animals, raising the possibility that this might be a hypomorphic model. Although the purified recombinant His-tagged ACAD10 Q635-I1059 C-terminus region used to generate the antibody confirmed the α-β-α tertiary fold of the ACAD-homologous region since it exhibited a visible UV spectrum characteristic of a bound flavin, attempts to express and purify a recombinant form of the full 1059 amino acid protein were unsuccessful (Fig. 1a-c) .
Characterization of mutant mice
Acad10-deficient mice become obese with age Acad10-deficient animals exhibited excess weight gain compared with wild-type control animals, which became more pronounced with age. This was seen in both males and females. Pathologic evaluation and micro-MRI demonstrated greater accumulation of white adipose tissue in deficient mice, especially abdominal subcutaneous and visceral fat. On micro-MRI, Acad10-deficient mice displayed excess adipose tissue at 2-3 months, progressing to a more significant increase at 7-8 months compared with wild-type mice. Both male and female Acad10-deficient mice demonstrated similar patterns and amounts of food consumption as controls, indicating that hyperphagia is not a significant factor (Supplemental Fig. 1a-f) . In open-field testing, mutant wild-type mice demonstrated smaller measures of movement over all, consistent with animal hypoactivity (Supplemental Fig. 2 ).
Histopathology A complete pathologic survey was performed on Acad10-deficient mouse tissues from young male (∼10-12 weeks) and older male (∼25-26 weeks) mice. Similar findings were seen in both groups. H&E staining revealed morphological abnormalities in deficient mice age 25-26 weeks, including small multifocal necroinflammatory lesions and early abscess formation in liver parenchyma (b), and extramedullary hematopoiesis with prominent megakaryocytes in spleen. Transmission electron microscopy of wildtype mouse liver and skeletal muscle from the hind leg was unremarkable, whereas Acad10-deficient liver and muscle showed subtle abnormalities with minimal accumulation of lipid droplets and occasional enlarged mitochondria. Alkaline phosphatase, Gomori trichrome, and nicotinamide adenine dinucleotide, reduced (NADH) dehydrogenase staining was performed on wild-type and mutant muscle tissues. Alkaline phosphatase staining showed peripheral nuclei indicative of chronic damage, Gomori trichrome staining an increase in fat accumulation in deficient animals, and NADH dehydrogenase staining an increased number of poorly staining muscle fibers (Supplemental Fig. 2a-f) .
A C A D 1 0 t i s s u e a n d s u b c e l l u l a r l o c a l i z a t i o n
Immunohistochemical staining demonstrated ACAD10 antigen in mitochondria of muscle and kidney. ACAD10 signal was detected in mitochondria and peroxisomes of the lung and pancreas but was restricted to mitochondria in muscle and kidney (Supplemental Fig. 3a, b) .
Biochemical phenotype Recurrent rhabdomyolysis, especially under conditions of physiologic stress and fasting, is a common clinical finding in ACAD deficiencies in humans and is felt to reflect energy deficit (Vockley et al. 2015) . Acad10-deficient mice showed a dramatic increase in creatine phosphokinase (CPK) upon overnight fasting. Acad10-deficient mice had normal levels of CRP and/or reduced cytokine Creatine kinase (CK) concentration in fasting Acad10-deficient male mice shows a statistically significant increase (3 animals were tested in each group, but the assays were performed only once due to blood volume required; two-tailed p value = 0.0135) compared with other fed or fasted animals at 8 months of age. Female animals had normal CK levels even when fasting. b C-reactive protein (CRP) concentration in wild-type and Acad10-deficient mice. Animals (∼8 months old) were fed ad lib or food was removed from cages; blood was drawn after fasting overnight (∼15 h). Bars show mean and standard deviation (SD) of 3 female and 3 male mice. CRP levels of each genotype and condition were compared.
Values between groups are not statistically significant, indicating lack of generalized inflammation or infectious process in the Acad10-deficient animals. Each assay was performed in triplicate. c Cytokine levels in blood from wild-type and Acad10-deficient male mice. Male animals were fed ad lib and blood was drawn. Bars show mean and SD of 7 male mice for each group. Cytokine levels of each genotype were compared. Values between groups with an asterisk (*) are statistically significant, indicating normal or reduced cytokine levels in the Acad10-deficient animals. Inset shows tunor necrosis factor alpha (TNF-α) and interleukin 13 (IL-13) levels. Note the different scale for the Y-axis. Female mice were not tested levels. However, tumor necrosis factor alpha (TNF-α), a marker of inflammation, was increased in deficient animals ( Fig. 2a-c) .
Acyl-CoA analysis of mouse blood and tissue extracts was performed using UPLC-MS/MS (Mihalik et al. 2010 Michaliszyn et al. 2012; Palladino et al. 2012) . The overall pattern of metabolic abnormalities was similar to that seen in adult obese patients with T2DM (Adams et al. 2009; Mihalik et al. 2010) . A variable pattern of elevated content of long straight-chain, and short terminal-branch-chained acylcarnitines observed in a variety of tissues from Acad10-deficient animals failed to suggest the enzymatic function of ACAD10. The free acyl-CoA profile in liver extracts showed a minimally abnormal pattern with a predominance of shortchain species (including some seen in ketosis), while muscle extract showed a mild increase of long-chain FAO intermediates. In both liver and muscle, a novel pattern of elevated 3-hydroxy short-chain dicarboxylic acid species was observed, which was unique to Acad10 deficiency (Table 1) . Acyl-CoAs not presented in the table did not differ between wild-type and mutant mice. Acylcarnitine profiling reflected the acyl-CoA results and are not presented.
ACAD10-deficient mice are insulin resistant and glucose intolerant Because of their striking obesity, Acad10-deficient mice were evaluated for insulin resistance, showing higher insulin levels at both fed and fasting conditions with normal random glucose levels, suggesting insulin resistance. Deficient male mice showed impaired glucose tolerance in an IPGTT test. Akt2 phosphorylation was decreased in both muscle and white adipose tissue in Acad10-deficient mice, demonstrating impaired insulin signaling (Fig. 3a-d) .
To further examine the insulin signaling pathway in Acad10-deficient mice, an expression array panel of genes involved in insulin regulation and T2DM was tested for expression in fat, liver, muscle, and brain. Significant downregulation was seen in expression of Hnf1b, Glp1r, Hnf4a, Fbp1, and Aqp2 (Supplemental Table 1 ). Increased expression of PEPCK, a key enzyme for gluconeogenesis and an indicator of hepatic insulin sensitivity, was confirmed by RT-PCR in Acad10-deficient mice (Supplemental Fig. 4A ).
Blue native PAGE Mitochondrial ETC abnormalities have previously been described in humans with obesity and T2DM (Kelley et al. 1999; Mihalik et al. 2010; Goodpaster 2013) . To examine ETC function in Acad10-deficient mice, BN-PAGE was performed on heart, liver, muscle, and brain tissue (Supplemental Fig. 4B ). ETC complex I activity was elevated in liver, muscle, and brain from deficient animals, suggestive of mitochondrial proliferation. Complex V activity was elevated in heart, liver, and muscle, but decreased in brain, suggesting the possibility of yet unrecognized neurologic problems.
Discussion
The most interesting phenotype of Acad10-deficient mice is the development of impaired glucose tolerance, peripheral insulin resistance, and abnormal weight gain. In addition, they exhibit the classic features of an ACAD deficiency, such as accumulation of metabolites consistent with abnormal mitochondrial metabolism and fasting induced rhabdomyolysis. The metabolite profile, rhabdomyolysis, and histologic findings in muscle suggest impaired energy metabolism. In liver and muscle, there is a nonspecific pattern of elevated shortchain 3-hydroxy-dicarboxylic acid common species in addition to novel ones, unlike those seen in known ACAD deficiencies. Additionally, there is a nonspecific variable pattern of elevated long, straight-chain, and short, terminal-branchchain ACNs in a variety of tissues. The significance of these abnormalities is unknown. An abnormal free acyl-CoA profile in liver with elevated short-and medium-chain acyl-CoAs, however, is not as consistent with impaired FAO as with the metabolic phenotype, as seen in obese T2DM patients (Kelley et al. 1999; Mihalik et al. 2010; Goodpaster 2013) . While mutant and wild-type animals consumed the same amount of food, the former exhibited considerably less movement in open-field testing, presumably either due to weakness or muscle pain, which may explain the excessive weight gain. Analysis of insulin-signaling pathways in the metabolically relevant tissues demonstrated decreased phosphorylation of Akt, a central mediator of the downstream insulin signaling pathway in both muscle and adipose tissue, as well as elevated expression level of PEPCK messenger RNA (mRNA) in the liver; this key regulatory enzyme of gluconeogenesis is negatively regulated by insulin under normal circumstances. Insulin resistance seen in this model could be secondary to obesity as well as ectopic lipid accumulation, especially in skeletal muscle and liver (Mihalik et al. 2010) . Lipid accumulation in muscle and liver of Acad10-deficient animals, along with impaired insulin sensitivity, is consistent with observations that dysregulation of FAO is related to obesity and T2DM (Lowell and Shulman 2005) . The association between Fig. 3 Acad10-deficient mice are insulin resistant. a Insulin concentrations in male Acad10 -/-mouse serum (n=3). Increased levels of insulin in fasting Acad10 knockout mice suggest insulin resistance in these mice. b Glucose concentrations in wild-type and Acad10-/-mouse serum. Animals (8 months old) were fed ad lib and random blood glucose measurements taken. Food was removed from cages and blood glucose levels measured after overnight fasting (∼15 h). Bars show mean and standard deviation (SD) of 3-4 female mice and 5-6 male mice. Glucose levels of each genotype and condition were compared. While glucose concentration in fasted Acad10-deficient male mice was slightly higher than for wild type, the difference was not statistically significant using an unpaired t test (two-tailed p values). Acad10-deficient females had significantly higher glucose levels than wild-type females. c. Intraperitoneal glucose tolerance test (IPGTT) on wild-type and Acad10-deficient mice. Acad10-deficient male mice show a statistically significant delay in glucose clearance (two-tailed p value=0.0201 and 0.0122, respectively) at 30 and 60 min compared with wild-type control mice of the same background. d Insulin signaling patterns in white adipose tissue and muscle from a male animal show a very similar pattern of high insulin resistance in peripheral tissues of the Acad10-deficient mice increased adiposity (total body, visceral, or abdominal subcutaneous) and insulin resistance is well characterized (Lebovitz and Banerji 2005) , and increased intramyocellular lipid droplets is a determinant of insulin resistance in obese children and adolescents (Weiss et al. 2003) . Many pathophysiological mechanisms have been shown to contribute to insulin resistance in obesity, including free fatty acids (FFA) and cytokines released from adipose tissue. Indeed, the Acad10-deficient mouse model did show an increase in TNF-α in blood, an indicator of inflammation (Fig. 2) . Further analysis of the insulin-signaling pathway and endoplasmic reticulum (ER) stress are necessary to unravel the specific abnormalities that contribute to impaired insulin sensitivity in Acad10-deficient animals.
Fatty acids have multiple other functions besides cellular fuel for generating energy. Most notably, long-chain fatty acids constitute the scaffold for synthesis of biologically active unsaturated complex fatty acids, such as prostaglandins and leukotrienes, which function in cellular signaling and regulation of inflammatory, immune, and other stress responses. ACAD10 may play a role in the metabolism of these compounds, the metabolic pathways of which include acyl-CoA intermediates.
Modern-day presentation of T2DM is overwhelmingly a lifestyle-associated disorder and is more strongly associated with nurture than nature. That said, the Native American Pima population are reported to have a 2-to 4-fold higher incidence of diabetes than the average American, and fivefold higher than the Pima population in Mexico (Pratley 1998; Bennett 1999; Valencia et al. 1999; Baier and Hanson 2004; Schulz et al. 2006) . Thus, it is clear that the T2DM is not solely related to ACAD10 dysfunction. Furthermore, it is not known how much the ACAD10 noncoding polymorphism found in the Pima affects enzyme level or function. Nevertheless, our results from a mouse model add evidence supporting a link between ACAD10 dysfunction and T2DM. As in humans, it is likely that other genes and environmental factors contribute to the phenotype seen in these animals, a possibility that could further be evaluated by transferring the mutation into different mouse strains.
Our results provide clues to a possible clinical phenotype for ACAD10 deficiency in humans. We predict either earlyonset insulin resistant diabetes of young people, an otherwise unexplained rhabdomyolysis, or both. Of note, both of these phenotypes can be seen independently in multiple genetic and metabolic disorders. Since many patients remain with an unrecognized genetic cause for their symptoms, despite complete evaluation for known causes, examination of this population for inactivating mutations in the ACAD10 gene becomes reasonable (Scalco et al. 2015) .
